Twist Bioscience
South San Francisco, US · 5 known investors
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
BiotechDeep TechSemiconductors
Investors · 5
In the news
- Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026 - BioSpacebiospace.com · 2026
- Twist Bioscience CFO Adam Laponis sells $226,307 in stock By Investing.cominvesting.com · 2026
- Is Twist Bioscience’s (TWST) AI Order Momentum Reshaping Its Core Life Sciences Investment Story? - Simply Wall St Newssimplywall.st · 2026
- Evercore ISI Raises its Price Target on Twist Bioscience (TWST)finance.yahoo.com · 2026
- Twist Bioscience stock rises as investors continue to reward stronger growth outlook and margin progress | Quiver Quantitativequiverquant.com · 2026
- Twist Bioscience Corp stock hits 52-week high at 89.71 USD By Investing.cominvesting.com · 2026